Spectroscopic investigation (FT-IR and FT-Raman), vibrational assignments, HOMO-LUMO analysis and molecular docking study of 2-(Adamantan-1-yl)-5-(4-nitrophenyl)-1,3,4-oxadiazole

Spectrochim Acta A Mol Biomol Spectrosc. 2015 Jan 25:135:973-83. doi: 10.1016/j.saa.2014.07.077. Epub 2014 Aug 8.

Abstract

FT-IR and FT-Raman spectra of 2-(Adamantan-1-yl)-5-(4-nitrophenyl)-1,3,4-oxadiazole were recorded and analyzed. The vibrational wavenumbers were computed using DFT quantum chemical calculations. The data obtained from wavenumber calculations are used to assign vibrational bands obtained experimentally. The energy barriers of the internal rotations about the C-C bonds connecting the oxadiazole to the adamantane and benzene rings are reported. The geometrical parameters (DFT) of the title compound are in agreement with the XRD results. The calculated HOMO and LUMO energies allow the calculations of atomic and molecular properties and they also showed that charge transfer occurs in the molecule. A detailed molecular picture of the title compound and its interactions were obtained from NBO analysis. As can be seen from the MEP map of the title compound, which regions having the negative potential are over the electro negative atoms, the region having the positive potential are over the phenyl and adamantine rings and the remaining species are surrounded by zero potential. The molecular docking studies reveal that the adamantyl derivative may exhibit C-South African HIV-proteas inhibitory activity.

Keywords: Adamantane; Docking; FT-IR; FT-Raman; MEP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adamantane / analogs & derivatives*
  • Adamantane / chemistry
  • Electrons*
  • Ligands
  • Models, Molecular
  • Molecular Conformation
  • Molecular Docking Simulation*
  • Nonlinear Dynamics
  • Optical Phenomena
  • Oxadiazoles / chemistry*
  • Quantum Theory
  • Spectroscopy, Fourier Transform Infrared
  • Spectrum Analysis, Raman*
  • Static Electricity
  • Thermodynamics
  • Vibration*

Substances

  • 2-(adamantan-1-yl)-5-(4-nitrophenyl)-1,3,4-oxadiazole
  • Ligands
  • Oxadiazoles
  • 1,3,4-oxadiazole
  • Adamantane